Who
Louisa Rodriguez
EVP Communications,PA & IR
Company insider
Files Form 4 as: EVP Communications,PA & IR, Cemex, S.A.B. de C.V. Sponsored ADR; Director, MSD Investment; Director, Orion Biotech Opportunities.
In numbers
- Trades disclosed
- 17
- Buys
- 6
- Sells
- 0
- Bought
- $474K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 29 Dec 2022
- Last trade
- 14 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 18 Aug 2026 | CX Cemex, S.A.B. de C.V. Sponsored ADRConstruction Materials | SEC FORM 4 Code A | —216,900 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CX Cemex, S.A.B. de C.V. Sponsored ADRConstruction Materials | SEC FORM 4 Code F | $1.2M96,640 at $12.13 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CX Cemex, S.A.B. de C.V. Sponsored ADRConstruction Materials | SEC FORM 4 Code A | —216,900 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CX Cemex, S.A.B. de C.V. Sponsored ADRConstruction Materials | SEC FORM 4 Code F | $1.2M96,640 at $12.13 | filing |
| 15 Jun 2026filed 17 Jun 2026 | CX Cemex, S.A.B. de C.V. Sponsored ADRConstruction Materials | SEC FORM 4 Code F | $219K17,887 at $12.25 | filing |
| 15 Jun 2026filed 17 Jun 2026 | CX Cemex, S.A.B. de C.V. Sponsored ADRConstruction Materials | SEC FORM 4 Code A | —31,981 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | CX Cemex, S.A.B. de C.V. Sponsored ADRConstruction Materials | SEC FORM 4 Code F | $219K17,887 at $12.25 | filing |
| 15 Jun 2026filed 17 Jun 2026 | CX Cemex, S.A.B. de C.V. Sponsored ADRConstruction Materials | SEC FORM 4 Code A | —31,981 at $0.00 | filing |
| 1 May 2026filed 1 May 2026 | CX Cemex, S.A.B. de C.V. Sponsored ADRConstruction Materials | SEC FORM 4 Code A | —32,657 at $0.00 | filing |
| 1 May 2026filed 1 May 2026 | CX Cemex, S.A.B. de C.V. Sponsored ADRConstruction Materials | SEC FORM 4 Code A | —32,657 at $0.00 | filing |
| 31 Oct 2024filed 4 Nov 2024 | MSD Investment | SEC FORM 4 Bought | $43K1,771.57 at $24.27 | filing |
| 27 Sep 2024filed 1 Oct 2024 | MSD Investment | SEC FORM 4 Bought | $70K2,908.21 at $24.05 | filing |
| 5 Jun 2024filed 7 Jun 2024 | MSD Investment | SEC FORM 4 Bought | $53K2,159.31 at $24.44 | filing |
| 17 May 2023filed 18 May 2023 | Orion Biotech Opportunitiesoption or derivative | SEC FORM 4 Code D | —40,000 at $0.00 | filing |
| 21 Apr 2023filed 25 Apr 2023 | MSD Investment | SEC FORM 4 Bought | $47K2,112 at $22.49 | filing |
| 8 Mar 2023filed 10 Mar 2023 | MSD Investment | SEC FORM 4 Bought | $29K1,236 at $23.06 | filing |
| 29 Dec 2022filed 3 Jan 2023 | MSD Investment | SEC FORM 4 Bought | $233K10,711 at $21.73 | filing |
News
No headline names them, or the companies they trade most, lately.